The US Food and Drug Administration has approved the first injectable medication for pre-exposure prophylaxis (PrEP) to lower the risk of getting HIV through sex, it announced Monday.
Apretude is approved for adults and teens who are at risk of getting HIV through sex and who weigh at least 77 pounds. It's given first as two shots a month apart, and every two months afterward.
PrEP was previously available only in the form of pills, Truvada and Descovy.
Click here for more information
Source: CNN health